Drugs / Tyrvaya Nasal Pump
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06329687 | Feb 2024 | dry eye syndrome | Oyster Point Pharma, Inc. | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tyrvaya Nasal Pump | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06329687 ↗ |
| Route | Intranasal | “Tyrvaya nasal pump” NCT06329687 ↗ |